Ongoing Projects
Lead Quadripartite organization: WHO
Project dates: January 2026 – December 2028 (36 months)
Overview:
Despite meaningful progress, critical gaps persist in fully operationalizing and sustaining joint AMR responses across sectors. The project strengthens the backbone of Egypt’s AMR containment efforts: enhancing national capacity, ensuring multisectoral engagement and enabling evidence-based action. The AMR MPTF programme supports four interconnected outcomes—governance, surveillance, stewardship, and financing.
Key activities include:
Lead Quadripartite organization: WHO
Project dates: January 2026 – December 2028 (36 months) phase 2 grant
Overview: An end-term review of the National Action Plan in 2022 reported over 50% implementation progress, particularly in surveillance and infection control, but persistent gaps remain in sustainable financing, implementation capacity, awareness, and AMU data availability. The project seeks to consolidate progress and build on the AMR MPTF Phase 1 achievements by strengthening governance, expanding surveillance, promoting stewardship, and embedding AMR awareness across all sectors.
Key activities include:
Lead Quadripartite organization: WHO
Project dates: January 2026 –January 2028 (24 months)
Overview: The country has established the foundations of a multisectoral One Health response to AMR through a coordination mechanism and a national action plan, but implementation remains constrained by limited governance capacity, financing, and cross-sector collaboration. The AMR MPTF project prioritizes integrating AMR risks into national planning and budgeting, strengthening surveillance systems, promoting rational antimicrobial use and safe disposal, and enhancing multisectoral coordination
Key activities include:
Lead Quadripartite organization: WOAH
Project dates: January 2026 – December 2028 (36 months) phase 2 grant
Overview: Kenya has made significant strides in combating AMR through a One Health approach with strong governance systems in place. The project scales up Kenya’s previous successes to sustain the gains, prioritise completion of phase 1 priorities and address identified gaps. The planned AMR interventions will further strengthen governance, expand surveillance, and improve stewardship and biosecurity across human, animal, and environmental sectors.
Key activities include:
Lead Quadripartite organization: FAO
Project dates: January 2026 – December 2028 (36 months)
Overview: With the current NAP concluding in 2025, the AMR MPTF project comes at a critical moment to support institutional readiness and evidence generation for developing the next multisectoral NAP in Kyrgyzstan. The AMR MPTF project will help address critical gaps identified during the previous NAP implementation, including weak environmental integration, limited intersectoral governance, and insufficient laboratory and veterinary capacity. The project will support the revision and operationalization of the NAP, ensuring stronger coordination, monitoring, and sustainable financing across human, animal, and environmental health sectors. By building sustainable structures, strengthening national ownership, and complementing ongoing initiatives, the project will help establish a strong foundation for Kyrgyzstan’s future AMR response.
Key activities include:
Lead Quadripartite organization: WHO
Project dates: February 2026 – January 2028 (24 months)
Overview: The compounded poly-crisis and multidimensional poverty in Lebanon has had its toll on the country’s infrastructure, public services and capacity of the government to address critical national public health issues. AMR is well-documented in Lebanon and recognized as a critical public health concern. There is an urgent need to build the capacity of all relevant sectors, in rational use of antibiotics and adapted solutions for waste management. It is imperative to monitor AMR through surveillance mechanisms and provide evidence for cost-effective and applicable policies at national level. The project supports Lebanon’s health, agriculture, and environmental system challenges by strengthening AMR surveillance, stewardship, and One Health coordination amid ongoing economic and governance challenges.
Key activities include:
Lead Quadripartite organization: FAO
Project dates: January 2026 – December 2028 (36 months)
Overview: Nepal has a high prevalence of infectious and communicable diseases including respiratory infections, tuberculosis and typhoid. The spread of AMR makes the treatment of such infections even more challenging. AMR has also developed in the livestock sector due to improper use of antimicrobials, lack of biosecurity measures and regulatory mechanisms. Environmental surveillance for AMR is limited and recent testing (2022) has shown resistant genes present in wastewater in the Kathmandu valley. AMR is recognized as an important health security threat in Nepal. The project advances Nepal’s recently endorsed AMR NAP (February 2024) by strengthening surveillance, improving antimicrobial use practices, and expanding One Health coordination across human, animal, food, and environmental sectors.
Key activities include:
Lead Quadripartite organization: WHO
Project dates: January 2026 – December 2028 (36 months)
Overview: AMR poses a serious and growing threat to health, food security, and the environment in the Philippines. The Philippines faces persistent challenges in ensuring rational antimicrobial use across sectors, maintaining effective surveillance, and building sustained behavior change. The project scales up stewardship, surveillance, and behaviour‑change interventions to support the Philippines’ 3rd National Action Plan on AMR and strengthen One Health integration across sectors.
Key activities include:
Lead Quadripartite organization: FAO
Project dates: March 2026 – February 2029 (36 months)
Overview: Sri Lanka has demonstrated strong commitment to addressing AMR through its National Strategic Plan (NSP) for Combating AMR 2023-2028 and Costed National Action Plan (NAP) emphasizing multisectoral collaboration across human health, animal health, and the environment. Critical gaps remain in surveillance systems, data integration, governance and coordination between sectors, including the need for updated regulation and new awareness campaigns. The key challenge for the implementation of NSP AMR is financial limitations. The AMR MPTF project strengthens Sri Lanka’s AMR governance, surveillance, and stewardship systems while integrating environmental dimensions and supporting the next NAP revision.
Key activities include:
Lead Quadripartite organization: WHO
Project dates: January 2026 – December 2028 (36 months) phase 2 grant
Overview: Zimbabwe took a major step forward in its efforts to combat antimicrobial resistance (AMR) with the launch of its second National Action Plan on AMR (NAP 2024–2028) on 20 February 2025. The updated NAP comes at a critical time, as drug resistance complications continue to be reported. High levels of resistance have been observed in common infections, largely driven by the misuse and overuse of antimicrobials. widespread use of antibiotics in food-producing animals, often without veterinary oversight, has further exacerbated resistance. Environmental contributors include contamination from waste and inadequate biosecurity practices, which facilitate the spread of resistant pathogens. The AMR MPTF project builds on Zimbabwe’s NAP 2.0 by strengthening surveillance, stewardship, environmental monitoring, and behaviour change to reduce AMR risks across sectors.
Key activities include: